纳米碳在甲状腺癌手术中甲状旁腺保护应用.docVIP

纳米碳在甲状腺癌手术中甲状旁腺保护应用.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
纳米碳在甲状腺癌手术中甲状旁腺保护应用

纳米碳在甲状腺癌手术中甲状旁腺保护应用   [摘要] 目的 探讨纳米碳在甲状腺癌术中的应用及其对甲状旁腺的保护作用。方法 根据患者术中是否应用纳米碳整群选取该院于2013年5月―2015年6月收治的94例甲状腺癌手术患者分成甲(应用了纳米碳)、乙(未应用纳米碳)两组各47例,观察两组手术效果。结果 术后,两组患者血钙与PTH水平差异有统计学意义(P0.05),且甲组出现低钙症状、PTH暂时性减低与PTH永久性减低发生率均显著低于乙组(P0.05);且甲组患者平均甲状旁腺数(2.85±0.79)枚,误切率为0%,同乙组的(2.05±0.72)枚、8.51%相比,差异有统计学意义(P0.05)。 结论 在临床甲状腺癌手术中,合理应用纳米碳,可明显减少患者低钙与HPT情况的发生率,降低甲状旁腺误切率,效果显著,值得推广。   [关键词] 甲状腺癌;纳米碳;甲状旁腺保护   [中图分类号] R5 [文献标识码] A [文章编号] 1674-0742(2016)03(c)-0130-03   Application of Nanocarbon in the Thyroid Cancer Operation and Protection Effect on Epithelial Body   LI Lei-lei, PENG Yun, QIU Zheng-lun   Third Department of General Surgery, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, Henan Province, 471009 China   [Abstract] Objective To discuss the application of nanocarbon in the thyroid cancer operation and protection effect on epithelial body. Methods 94 cases of patients with thyroid cancer operation admitted and treated in our hospital from May 2013 to June 2015 were divided into the group A (applied nanocarbon) and the group B (did not apply nanocarbon) with 47 cases in each, the operative effects of the two groups were observed. Results The differences in the blood calcium and PTH level between the two groups were obvious after operation, P0.05, the incidence rates of symptomatic hypocalcemia, PTH temporary reduction and PTH permanent reduction in the group A were obviously lower than those in the group B, P0.05, and the differences in the average epithelial body number and mal-cut rate between the group A and the group B were obvious [(2.85±0.79) vs (2.05±0.72)], (0% vs 8.51%), P0.05. Conclusion The reasonable application of nanocarbon in the thyroid cancer operation in clinic can obviously reduce the incidence rate of low calcium and HPT of patients and reduce the mal-cut rate of epithelial body with the obvious effect, which is worth promotion.   [Key words] Thyroid cancer; Nanocarbon; Epithelial body protection   该研究整群选取该院于2013年5月―2015年6月收治的94

文档评论(0)

189****7685 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档